Abstract
We describe a material of 577 infants born of epileptic women treated with anticonvulsants in monotherapy during early pregnancy and collected from France, Italy, and Sweden. The incidence of major malformations is increased compared with the general population but no definite difference in risk can be demonstrated between the various anticonvulsants, but valproic acid was associated with a doubling of the average risk. The increased risk for facial clefts and for cardiac malformations, described from most studies on epilepsy during pregnancy, cannot be seen in this material. Unusually many cases of penis abnormalities (micropenis, hypospadias) were noted. An effect on fetal growth can be demonstrated and is apparently more pronounced for carbamazepine than for the other drugs. It results in a reduced birth weight in spite of normal gestational length, reduced body length and head circumference. The possible biological significance of this finding is discussed.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
AnnegersJ.F., KurlandL.T. and HauserW.A. (1983): Teratogenicity of anticonvulsant drugs. In: Ward A.A. Jr., Penry J.K., Purpura D., (eds.) Epilepsy, Raven Press, New York. pp. 239–248.
BéthenodM. and FrédérichA. (1975): Les enfants des antiépileptiques. - Pediatrie 30: 227–248.
BossiL. (1983): Fetal effects of anticonvulsants. In: MorselliP.L., PippengerC.D., PenryJ.K., eds. Antiepileptic Drug Therapy in Pediatrics, ed. by Raven Press, New York. pp. 37–64.
ElshoveJ. and vanEckJ.H.M. (1971): Aangeboren misvormingen met name gespleten lip met of zonder gespleten verhemelte, bij kinderen van moeders met epilepsie. - Ned. Tijdschr. Geneesk. 115: 1371.
Ericson A., Eriksson M., Källén B. and Meirik O. (1986): Birth weight distribution as an indicator of environmental effects on fetal development. -Scand. J. Soc. Med. in press.
FeldmanG.L., WeaverD.D. and LovrienE.W. (1977): The fetal trimethadone syndrome. Report of an additional family and further delineation of this syndrome. - Am. J. Dis. Child. 131: 1389–1392.
JanzD. and FuchsU. (1964): Sind antiepileptische Med kamente während der Schwangerschaft schädlich?- Dtsch. Med. Wschr. 89: 241–248.
HanssonJ.W., MyrianthopoulosN.C., Sedgwick HarveryM.A. and SmithD.W. (1976): Risks of the offspring of women treated with hydantoin anticonvulsants, with emphasis on the fetal hydantoin syndrome. - J. Pediatr. 89: 662–668.
HiilesmaaV.K., TeramoK., GranströmM-L. and BardyA.H. (1981): Fetal head growth retardation associated with maternal antiepileptic drugs. -Lancet ii: 165–167.
HillR.M., VarniaudW.M., HorningM.G., McCulleyL.B. and MorganN.F. (1974): Infants exposed in utero to antiepileptic drugs. - Am. J. Dis. Child. 127: 645–653.
KällénB. (1986): A register study of maternal epilepsy and delivery outcome with special reference to drug use. - Acta Neurol. Scand. 73: 253–259.
MeadowS.R. (1968): Anticonvulsant drugs and congenital abnormalities. - Lancet ii: 1296.
RobertE., LöfkvistE. and MauguièreF. (1984): Valproate and spina bifida. - Lancet ii: 1392.
Robert E., Löfkvist E., Mauguière F. and Robert J.M. (1986): Evaluation of drug therapy and teratogenic risks in a Rhone Alps district population of pregnant epileptic women. - Europ. Neurol. in press.
Teratogenic risks of antiepileptic drugs with special reference to sodium valproate (valproic acid) therapy. A Collaborative Study of the French Chapter of I.L.A.E. (1984). In: Porter E.J. et al., (eds.) Advances in Epileptology: XVth Epilepsy International Symposium. Raven. Press, New York. pp. 299–307.
Author information
Authors and Affiliations
Consortia
Additional information
Corresponding author.
Rights and permissions
About this article
Cite this article
Bertollini, R., Källen, B., Mastroiacovo, P. et al. Anticonvulsant drugs in monotherapy. Effect on the fetus. Eur J Epidemiol 3, 164–171 (1987). https://doi.org/10.1007/BF00239754
Issue Date:
DOI: https://doi.org/10.1007/BF00239754